A double-blind, randomized clinical trial of dietary supplementation on cognitive and immune functioning in healthy older adults

BMC Complementary and Alternative Medicine

Volumn 14, Issue , 2014, Pages

  Lewis, John E ^a   Melillo, Angelica B ^a   Tiozzo, Eduard ^a   Chen, Lawrence ^a   Leonard, Susanna ^a   Howell, Mark ^a   Diaz, Janelle ^a   Gonzalez, Kathy ^a   Woolger, Judi M ^a   Konefal, Janet ^a   Paterson, Elaine ^b   Barnes, David ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Standard Process Inc   (United States)

Author keywords

Choline; Cognitive functioning; Controlled oral word association; Dietary supplement; Epidermal growth factor; Ginkgo biloba; Immune functioning; Older adults; Trail making test

Indexed keywords

CHOLINE; EPIDERMAL GROWTH FACTOR; PLANT EXTRACT;

AGED; COGNITION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; GINKGO BILOBA; HUMAN; IMMUNITY; MALE; MEMORY; METABOLISM; MIDDLE AGED; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CHOLINE; COGNITION; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; EPIDERMAL GROWTH FACTOR; FEMALE; GINKGO BILOBA; HUMANS; IMMUNITY; MALE; MEMORY; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; REFERENCE VALUES;

EID: 84893170093     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-14-43     Document Type: Article

References (33)

1. Beers MH, Berkow R. The Merck Manual of Geriatrics 2000, Whitehouse Station, NJ: Merck Research Laboratories.
2. Association A. Alzheimer's disease facts and figures. Alzheimers Dement 2012, 2012(8):131-168.
3. Nutrition Business Journal Nutrition Business Journal Supplement Business Report 2010 2010, Cleveland, OH: Pendon Media, Inc., Nutrition Business Journal.
4. National Health and Nutrition Examination Survey III: Use of Dietary Supplements. http://www.cdc.gov/nchs/data/nhanes/databriefs/dietary.pdf.
5. Winslow LC, Kroll DJ. Herbs as medicines. Arch Intern Med 1998, 158:2192-2199.
6. Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA 2002, 288:835-840.
7. Mix JA, Crews WD. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults. J Altern Complement Med 2000, 6:219-229.
8. Ernst E. The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 2002, 136:42-53.
9. Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998, 55:1409-1415.
10. Wang J, Ho L, Zhao W, Ono K, Rosensweig C, Chen L, Humala N, Teplow DB, Pasinetti GM. Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease. J Neurosci 2008, 28:6388-6392.
11. Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, Perry VH. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003, 74:788-789.
12. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005, 64:1371-1377.
13. Kolb B, Wishaw IQ. Fundamentals of Human Neuropsychology 1990, New York: Freeman.
14. Golden CJ. Stroop Color and Word Test Manual 1978, Chicago: Stoelting Company.
15. Lezak MO. Neuropsychological Assessment 1995, New York: Oxford University Press.
16. Reitan RM. Trail Making Test Manual for Administration and Scoring 1992, Tucson, AZ: Reitan Neuropsychology Laboratory.
17. Loonstra AS, Tarlow AR, Sellers AH. COWAT metanorms across age, education, and gender. Appl Neuropsychol 2001, 8:161-166.
18. Wechsler D. The Wechsler Adult Intelligence Scale-revised 1981, NY: The Psychological Corporation.
19. Brandt J, Benedict R. Hopkins Verbal Learning Test-revised 2001, Lutz, FL: Psychological Assessment Resources, Inc.
20. Kortte KB, Horner MD, Windham WK. The trail making test, part B: cognitive flexibility or ability to maintain set?. Appl Neuropsychol 2002, 9:106-109.
21. Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control: validation using a set-switching paradigm. J Clin Exp Neuropsychol 2000, 22:518-528.
22. Sumerall SW, Timmons PL, James AL, Ewing MJ, Oehlert ME. Expanded norms for the controlled oral word association test. J Clin Psychol 1997, 53:517-521.
23. Miceli G, Caltagirone C, Gainotti G, Masullo C, Silveri MC. Neuropsychological correlates of localized cerebral lesions in non-aphasic brain-damaged patients. J Clin Neuropsychol 1981, 3:53-63.
24. Murdoch BE, Chenery HJ, Wilks V, Boyle RS. Language disorders in dementia of the Alzheimer type. Brain Lang 1987, 31:122-137.
25. Napryeyenko O, Sonnik G, Tartakovsky I. Efficacy and tolerability of Ginkgo biloba extract EGb 761 by type of dementia: analyses of a randomised controlled trial. J Neurol Sci 2009, 283:224-229.
26. O'Bryant SE, Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, Waring S, az-Arrastia R. A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol 2010, 67:1077-1081.
27. Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, Volpato S, Atti AR, Ble A, Fellin R. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res 2007, 41:686-693.
28. Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 2004, 59:21-26.
29. Marksteiner J, Kemmler G, Weiss EM, Knaus G, Ullrich C, Mechtcheriakov S, Oberbauer H, Auffinger S, Hinterholzl J, Hinterhuber H, et al. Five out of 16 plasma signaling proteins are enhanced in plasma of patients with mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2011, 32:539-540.
30. Chen-Plotkin AS, Hu WT, Siderowf A, Weintraub D, Goldmann GR, Hurtig HI, Xie SX, Arnold SE, Grossman M, Clark CM, et al. Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol 2011, 69:655-663.
31. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med 2010, 362:329-344.
32. Lee KS, Chung JH, Choi TK, Suh SY, Oh BH, Hong CH. Peripheral cytokines and chemokines in Alzheimer's disease. Dement Geriatr Cogn Disord 2009, 28:281-287.
33. Rocha NP, Teixeira AL, Coelho FM, Caramelli P, Guimaraes HC, Barbosa IG, da Silva TA, Mukhamedyarov MA, Zefirov AL, Rizvanov AA, et al. Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with beta-amyloid peptide. Mol Cell Neurosci 2012, 49:77-84.